Professor Anthony (Tony) Webber - CEO, Clinical Network Services (CNS) Pty Ltd
Professor Tony Webber is a pioneer of the Biotechnology Industry in Queensland whose leadership and achievements over the past three decades are inspirational.
Following appointment as Head of the School of Health Science at the then QIT in 1980, Tony set about fostering applied research collaborations with industry.
Leading by example, Tony secured a $1M contract in 1981 with Fielder Gillespie Ltd to establish the faculty's Centre for Applied Immunology (CAI), whose aim was to develop monoclonal antibody-based diagnostics. Highly successful outcomes include the D-dimer technology for the detection of blood clots in humans that was marketed by MABco Pty Ltd, an early 'spinout' company in Queensland.
In 1986, MABco was sold to AGEN who took the company public. Over the next decade, Tony instigated the formation of GeneCo Pty Ltd by the QUT Foundation with AGEN and QIDC as shareholders, and served as its Managing Director. GeneCo outsourced its R&D to the QUT Centre for Molecular Biotechnology, resulting in patented IP that was pivotal in QUT being awarded the CRC for Diagnostics in 1996.
After retiring from QUT in 1996, Tony set about establishing his 'second career' in the sector. In 1998, he formed Clinical Network Services (CNS) Pty Ltd, a successful, Queensland-based clinical contract research organisation that today employs 18 staff.
From the outset, Tony focused on winning business from US-based biotechnology companies. He exhibited at BIO for the first time in 1997 and has been doing so ever since.
Under Tony's leadership, Smart State funds were secured from the Queensland Government to establish the Queensland Clinical Trials Network (QCTN) in 2005 as an industry body to promote the biotechnology sector in Queensland.
In his role as President and Chairman of the QCTN Management Committee, Tony's statesmen-like leadership has made a significant contribution to the forging of strong links between QCTN and cognate bodies internationally.
Professor Anthony (Tony) Webber - CEO, Clinical Network Services (CNS) Pty Ltd
Professor Tony Webber is a pioneer of the Biotechnology Industry in Queensland whose leadership and achievements over the past three decades are inspirational.
Following appointment as Head of the School of Health Science at the then QIT in 1980, Tony set about fostering applied research collaborations with industry.
Leading by example, Tony secured a $1M contract in 1981 with Fielder Gillespie Ltd to establish the faculty's Centre for Applied Immunology (CAI), whose aim was to develop monoclonal antibody-based diagnostics. Highly successful outcomes include the D-dimer technology for the detection of blood clots in humans that was marketed by MABco Pty Ltd, an early 'spinout' company in Queensland.
In 1986, MABco was sold to AGEN who took the company public. Over the next decade, Tony instigated the formation of GeneCo Pty Ltd by the QUT Foundation with AGEN and QIDC as shareholders, and served as its Managing Director. GeneCo outsourced its R&D to the QUT Centre for Molecular Biotechnology, resulting in patented IP that was pivotal in QUT being awarded the CRC for Diagnostics in 1996.
After retiring from QUT in 1996, Tony set about establishing his 'second career' in the sector. In 1998, he formed Clinical Network Services (CNS) Pty Ltd, a successful, Queensland-based clinical contract research organisation that today employs 18 staff.
From the outset, Tony focused on winning business from US-based biotechnology companies. He exhibited at BIO for the first time in 1997 and has been doing so ever since.
Under Tony's leadership, Smart State funds were secured from the Queensland Government to establish the Queensland Clinical Trials Network (QCTN) in 2005 as an industry body to promote the biotechnology sector in Queensland.
In his role as President and Chairman of the QCTN Management Committee, Tony's statesmen-like leadership has made a significant contribution to the forging of strong links between QCTN and cognate bodies internationally.